Related Experiment Video
Updated: Jan 18, 2026

Author Spotlight: Collecting the Brain and Serum from the Same Mice Fetus to Study Brain Tumor Development
Published on: May 17, 2024
Perspectives on newborn screening for Fabry disease based on mothers' experiences in Japan
Noriko Sasaki1, Yoko Nakajima2, Yukari Hibino3
1Matsunami Research Park, Kasamatsu, Gifu, Japan.
Insights
Newborn screening for Fabry disease (FD) can cause maternal anxiety during the asymptomatic period. Support, like genetic counseling, can ease this burden and improve screening effectiveness.
Area of Science:
- Genetics
- Pediatrics
- Psychology
Background:
- Newborn screening (NBS) for Fabry disease (FD) enables early treatment but raises concerns about prolonged uncertainty for families.
- Mothers, often heterozygous carriers and primary caregivers, are particularly affected by the psychological impact of asymptomatic FD diagnoses in their children.
Purpose of the Study:
- To explore the experiences, emotions, and support needs of mothers whose children were diagnosed with FD via NBS.
- To understand the psychological impact of the asymptomatic period on these mothers and identify areas for improved support.
Main Methods:
- Qualitative study involving semistructured interviews with five mothers of children diagnosed with FD through NBS.
- Analysis of interview data using the KJ (Kawakita Jiro) method, a bottom-up qualitative approach.
Main Results:
- Mothers experienced a significant psychological burden due to monitoring for FD symptom onset.
- This burden was mitigated by understanding disease onset timing, physician input, time, and personal coping mechanisms.
- Mothers expressed a need for better disease information, empathy, and peer support, with mixed feelings about NBS discovery.
Conclusions:
- Understanding mothers' experiences is crucial for effective FD NBS implementation.
- Providing enhanced support, including genetic counseling and peer networks, can alleviate maternal anxiety and improve the overall NBS experience.
- Addressing the psychological impact on caregivers is essential for optimizing early detection strategies in genetic diseases.
Abstract:
Newborn screening (NBS) for Fabry disease (FD) is an effective way to identify individuals with FD before the onset of symptoms, enabling early therapeutic treatment. The classic form of FD typically begins in early childhood or later, but the late-onset form often develops in adulthood. However, FD-NBS identifies positive cases regardless of the expected timing of symptom onset. Consequently, concerns have been raised about prolonged uncertainty, medicalization, and caregivers' hypervigilance throughout the asymptomatic period. These issues are particularly salient for mothers, who are often heterozygous carriers and primary caregivers. Despite the growing implementation of FD-NBS in some countries, the perspectives of parents, especially mothers, have not been adequately explored. This study explores the experiences, emotions, and needs of five mothers whose children were diagnosed with FD through NBS, aiming to uncover the psychological impact and support required during the asymptomatic period. Semistructured interviews were conducted and analyzed using the KJ (Kawakita Jiro) method, a kind of bottom-up qualitative approach. The findings revealed that mothers experienced a psychological burden related to monitoring for disease onset. However, this burden was reduced by several factors, including an understanding of the timing of onset, the attending physician's opinions, the passage of time, and personalized coping strategies. Needs were identified for support in understanding the disease, as well as for spaces that facilitate empathy and information exchange. Opinions regarding FD-NBS were generally positive; however, negative feelings were also expressed, including views that they did not have to discover their child's FD through NBS. These findings suggest that understanding the experiences of mothers of asymptomatic children and providing support, such as genetic counseling and peer support, could enhance the effectiveness of FD-NBS.
More Related Videos
10:16In Vitro Enzyme Measurement to Test Pharmacological Chaperone Responsiveness in Fabry and Pompe Disease
Published on: December 20, 2017
05:58Digital Polymerase Chain Reaction Assay for the Genetic Variation in a Sporadic Familial Adenomatous Polyposis Patient Using the Chip-in-a-tube Format
Published on: August 20, 2018